Review Article
Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities
| | α-KG | Alpha-ketoglutarate | | 1,3DPG | 1,3-Diphosphoglycerate | | 6PG | 6-Phosphogluconate | | E4P | Erythrose-4-phosphate | | FAO | Fatty acid oxidation | | FFA | Free fatty acid | | F6P | Fructose-6-phosphate | | F1,6BP | Fructose-1,6-bisphosphate | | G6P | Glucose-6-phosphate | | GAP | Glyceraldehyde-3-phosphate | | LCFA | Long-chain fatty acids | | NTP | Nucleoside triphosphate | | OXPHOS | Oxidative phosphorylation | | PEP | Phosphoenolpyruvate | | PPP | Pentose phosphate pathway | | PUFA | Polyunsaturated fatty acid | | R5P | Ribose-5-phosphate | | Ru5P | Ribulose-5-phosphate | | S7P | Sedoheptulose-7-phosphate | | X5P | Xylulose-5-phosphate |
|
|